H. Salkin Et Al. , "Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells.," Brain research , vol.1808, pp.148354, 2023
Salkin, H. Et Al. 2023. Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells.. Brain research , vol.1808 , 148354.
Salkin, H., Satir-Basaran, G., Korkmaz, S., Burcin Gonen, Z., & Erdem Basaran, K. E., (2023). Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells.. Brain research , vol.1808, 148354.
Salkin, Hasan Et Al. "Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells.," Brain research , vol.1808, 148354, 2023
Salkin, Hasan Et Al. "Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells.." Brain research , vol.1808, pp.148354, 2023
Salkin, H. Et Al. (2023) . "Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells.." Brain research , vol.1808, p.148354.
@article{article, author={Hasan Salkin Et Al. }, title={Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells.}, journal={Brain research}, year=2023, pages={148354} }